Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH agonist stop-antagonist versus GnRH antagonist protocol in poor ovarian responders undergoing IVF
IRCT20110731007165N10Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2020
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of gonadotropin-releasing hormone agonist in infertility and poor ovarian response (POR) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Number of oocytes, Number of MII oocytes and 2 more. Started Dec 2020; status: completed.
02
Drugs
gonadotropin-releasing hormone agonist
03
Conditions
infertilitypoor ovarian response (POR)
Beyond the preview
Go deeper on IRCT20110731007165N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110731007165N10.